Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits

Qianhong Li, Roberto Bolli, Yumin Qiu, Xian Liang Tang, Sidney S. Murphree, Brent A. French

Research output: Contribution to journalArticle

Abstract

Background - Administration of Cu/Zn superoxide dismutase (SOD) without catalase fails to alleviate myocardial stunning, but extracellular SOD (Ec- SOD) may be more effective because it binds to heparan sulfate proteoglycans on the cellular glycocalyx. We therefore used in vivo gene transfer to increase systemic levels of Ec-SOD and determined whether this gene therapy protects against myocardial stunning. Methods and Results - The cDNA for human Ec-SOD was cloned behind the cytomegalovirus (CMV) promoter and incorporated into a replication-deficient adenovirus (Ad5/CMV/Ec-SOD). Injection of this virus (2x108 pfu/kg IV) produced high levels of Ec-SOD in the liver, which could be redistributed to the heart and other organs by injection of heparin. Conscious rabbits underwent a sequence of six 4-minute coronary occlusion/4-minute reperfusion cycles for 3 consecutive days starting 3 days after intravenous injection of Ad5/CMV/Ec-SOD or Ad5/CMV/nls/LacZ (negative control). Both groups were given heparin (2000 U/kg IV) 2 hours before the first sequence of occlusions. The severity of myocardial stunning was measured as the total deficit of LV wall thickening after the last reperfusion. On day 1, the total deficit of wall thickening was markedly decreased in Ad5/CMV/Ec-SOD rabbits versus controls and similar to that seen on days 2 and 3 in controls. Conclusions - The results demonstrate that in vivo gene transfer of the CDNA encoding Ec-SOD provides the heart with substantial protection against myocardial stunning without the need for concomitant administration of catalase. The present observations provide the basis for controlling gene therapy at the posttranslational level and for simultaneously protecting multiple organs from oxidant stress.

Original languageEnglish (US)
Pages (from-to)1438-1448
Number of pages11
JournalCirculation
Volume98
Issue number14
StatePublished - Oct 6 1998
Externally publishedYes

Fingerprint

Myocardial Stunning
Genetic Therapy
Superoxide Dismutase
Rabbits
Cytomegalovirus
Catalase
Reperfusion
Heparin
Glycocalyx
Heparan Sulfate Proteoglycans
Injections
Coronary Occlusion
Oxidants
Adenoviridae
Intravenous Injections
Genes
Complementary DNA
Viruses
Liver

Keywords

  • Free radicals
  • Genes
  • Ischemia
  • Reperfusion
  • Stunning, myocardial
  • Superoxide dismutase

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Li, Q., Bolli, R., Qiu, Y., Tang, X. L., Murphree, S. S., & French, B. A. (1998). Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation, 98(14), 1438-1448.

Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. / Li, Qianhong; Bolli, Roberto; Qiu, Yumin; Tang, Xian Liang; Murphree, Sidney S.; French, Brent A.

In: Circulation, Vol. 98, No. 14, 06.10.1998, p. 1438-1448.

Research output: Contribution to journalArticle

Li, Q, Bolli, R, Qiu, Y, Tang, XL, Murphree, SS & French, BA 1998, 'Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits', Circulation, vol. 98, no. 14, pp. 1438-1448.
Li Q, Bolli R, Qiu Y, Tang XL, Murphree SS, French BA. Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation. 1998 Oct 6;98(14):1438-1448.
Li, Qianhong ; Bolli, Roberto ; Qiu, Yumin ; Tang, Xian Liang ; Murphree, Sidney S. ; French, Brent A. / Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. In: Circulation. 1998 ; Vol. 98, No. 14. pp. 1438-1448.
@article{aa16c5a02fc74afaa03f14092deba302,
title = "Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits",
abstract = "Background - Administration of Cu/Zn superoxide dismutase (SOD) without catalase fails to alleviate myocardial stunning, but extracellular SOD (Ec- SOD) may be more effective because it binds to heparan sulfate proteoglycans on the cellular glycocalyx. We therefore used in vivo gene transfer to increase systemic levels of Ec-SOD and determined whether this gene therapy protects against myocardial stunning. Methods and Results - The cDNA for human Ec-SOD was cloned behind the cytomegalovirus (CMV) promoter and incorporated into a replication-deficient adenovirus (Ad5/CMV/Ec-SOD). Injection of this virus (2x108 pfu/kg IV) produced high levels of Ec-SOD in the liver, which could be redistributed to the heart and other organs by injection of heparin. Conscious rabbits underwent a sequence of six 4-minute coronary occlusion/4-minute reperfusion cycles for 3 consecutive days starting 3 days after intravenous injection of Ad5/CMV/Ec-SOD or Ad5/CMV/nls/LacZ (negative control). Both groups were given heparin (2000 U/kg IV) 2 hours before the first sequence of occlusions. The severity of myocardial stunning was measured as the total deficit of LV wall thickening after the last reperfusion. On day 1, the total deficit of wall thickening was markedly decreased in Ad5/CMV/Ec-SOD rabbits versus controls and similar to that seen on days 2 and 3 in controls. Conclusions - The results demonstrate that in vivo gene transfer of the CDNA encoding Ec-SOD provides the heart with substantial protection against myocardial stunning without the need for concomitant administration of catalase. The present observations provide the basis for controlling gene therapy at the posttranslational level and for simultaneously protecting multiple organs from oxidant stress.",
keywords = "Free radicals, Genes, Ischemia, Reperfusion, Stunning, myocardial, Superoxide dismutase",
author = "Qianhong Li and Roberto Bolli and Yumin Qiu and Tang, {Xian Liang} and Murphree, {Sidney S.} and French, {Brent A.}",
year = "1998",
month = "10",
day = "6",
language = "English (US)",
volume = "98",
pages = "1438--1448",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "14",

}

TY - JOUR

T1 - Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits

AU - Li, Qianhong

AU - Bolli, Roberto

AU - Qiu, Yumin

AU - Tang, Xian Liang

AU - Murphree, Sidney S.

AU - French, Brent A.

PY - 1998/10/6

Y1 - 1998/10/6

N2 - Background - Administration of Cu/Zn superoxide dismutase (SOD) without catalase fails to alleviate myocardial stunning, but extracellular SOD (Ec- SOD) may be more effective because it binds to heparan sulfate proteoglycans on the cellular glycocalyx. We therefore used in vivo gene transfer to increase systemic levels of Ec-SOD and determined whether this gene therapy protects against myocardial stunning. Methods and Results - The cDNA for human Ec-SOD was cloned behind the cytomegalovirus (CMV) promoter and incorporated into a replication-deficient adenovirus (Ad5/CMV/Ec-SOD). Injection of this virus (2x108 pfu/kg IV) produced high levels of Ec-SOD in the liver, which could be redistributed to the heart and other organs by injection of heparin. Conscious rabbits underwent a sequence of six 4-minute coronary occlusion/4-minute reperfusion cycles for 3 consecutive days starting 3 days after intravenous injection of Ad5/CMV/Ec-SOD or Ad5/CMV/nls/LacZ (negative control). Both groups were given heparin (2000 U/kg IV) 2 hours before the first sequence of occlusions. The severity of myocardial stunning was measured as the total deficit of LV wall thickening after the last reperfusion. On day 1, the total deficit of wall thickening was markedly decreased in Ad5/CMV/Ec-SOD rabbits versus controls and similar to that seen on days 2 and 3 in controls. Conclusions - The results demonstrate that in vivo gene transfer of the CDNA encoding Ec-SOD provides the heart with substantial protection against myocardial stunning without the need for concomitant administration of catalase. The present observations provide the basis for controlling gene therapy at the posttranslational level and for simultaneously protecting multiple organs from oxidant stress.

AB - Background - Administration of Cu/Zn superoxide dismutase (SOD) without catalase fails to alleviate myocardial stunning, but extracellular SOD (Ec- SOD) may be more effective because it binds to heparan sulfate proteoglycans on the cellular glycocalyx. We therefore used in vivo gene transfer to increase systemic levels of Ec-SOD and determined whether this gene therapy protects against myocardial stunning. Methods and Results - The cDNA for human Ec-SOD was cloned behind the cytomegalovirus (CMV) promoter and incorporated into a replication-deficient adenovirus (Ad5/CMV/Ec-SOD). Injection of this virus (2x108 pfu/kg IV) produced high levels of Ec-SOD in the liver, which could be redistributed to the heart and other organs by injection of heparin. Conscious rabbits underwent a sequence of six 4-minute coronary occlusion/4-minute reperfusion cycles for 3 consecutive days starting 3 days after intravenous injection of Ad5/CMV/Ec-SOD or Ad5/CMV/nls/LacZ (negative control). Both groups were given heparin (2000 U/kg IV) 2 hours before the first sequence of occlusions. The severity of myocardial stunning was measured as the total deficit of LV wall thickening after the last reperfusion. On day 1, the total deficit of wall thickening was markedly decreased in Ad5/CMV/Ec-SOD rabbits versus controls and similar to that seen on days 2 and 3 in controls. Conclusions - The results demonstrate that in vivo gene transfer of the CDNA encoding Ec-SOD provides the heart with substantial protection against myocardial stunning without the need for concomitant administration of catalase. The present observations provide the basis for controlling gene therapy at the posttranslational level and for simultaneously protecting multiple organs from oxidant stress.

KW - Free radicals

KW - Genes

KW - Ischemia

KW - Reperfusion

KW - Stunning, myocardial

KW - Superoxide dismutase

UR - http://www.scopus.com/inward/record.url?scp=0032491202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032491202&partnerID=8YFLogxK

M3 - Article

C2 - 9760299

AN - SCOPUS:0032491202

VL - 98

SP - 1438

EP - 1448

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 14

ER -